About Klinikum Bremen-Mitte gGmbH; Frauenklinik
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AGO Study Group
2
Hoffmann-La Roche
1
Philipps University Marburg Medical Center
1
Clinical Trials at Klinikum Bremen-Mitte gGmbH; Frauenklinik
During the past decade, Klinikum Bremen-Mitte gGmbH; Frauenklinik conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Randomized Multicenter Trial With SU11248 Evaluating Dosage,Tolerability,Toxicity and Effectiveness of a Multitargeted Receptor Tyrosine Kinase Inhibitor
2007-09-01
Completed
73
Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors
2008-06-01
2012-01-01
Completed
41
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Klinikum Bremen-Mitte gGmbH; Frauenklinik"
#1 collaborator was "German Cancer Aid" with 1 trials as a collaborator, "HSK Reasearch GmbH Wiesbaden" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Philipps University Marburg Medical Center" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Klinikum Bremen-Mitte gGmbH; Frauenklinik
According to Clinical.Site data, the most researched conditions in "Klinikum Bremen-Mitte gGmbH; Frauenklinik" are
"Breast Cancer" (1 trials), "Cancer of Endometrium Stage I" (1 trials), "Cancer of Endometrium Stage II" (1 trials), "Cancer of the Fallopian Tube" (1 trials) and "Carcinosarcoma" (1 trials). Many other conditions were trialed in "Klinikum Bremen-Mitte gGmbH; Frauenklinik" in a lesser frequency.
Clinical Trials Intervention Types at Klinikum Bremen-Mitte gGmbH; Frauenklinik
Most popular intervention types in "Klinikum Bremen-Mitte gGmbH; Frauenklinik" are "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (1 trials), "Carboplatin" (1 trials), "PegLiposomal Doxorubicin" (1 trials), "Pertuzumab" (1 trials) and "SUNITINIB" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Klinikum Bremen-Mitte gGmbH; Frauenklinik
The vast majority of trials in "Klinikum Bremen-Mitte gGmbH; Frauenklinik" are
4 trials for "Female" genders.
Clinical Trials Status at Klinikum Bremen-Mitte gGmbH; Frauenklinik
Currently, there are NaN active trials in "Klinikum Bremen-Mitte gGmbH; Frauenklinik".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Klinikum Bremen-Mitte gGmbH; Frauenklinik,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Klinikum Bremen-Mitte gGmbH; Frauenklinik, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".